These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery. Zhang B, Maeda N, Okada K, Tatsukawa M, Sawayama Y, Matsunaga A, Kumagai K, Miura S, Nagao T, Hayashi J, Saku K. Atherosclerosis; 2006 Jul; 187(1):205-12. PubMed ID: 16236285 [Abstract] [Full Text] [Related]
6. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group. Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [Abstract] [Full Text] [Related]
11. Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis. Zhang B, Kaneshi T, Ohta T, Saku K. J Lipid Res; 2005 Oct; 46(10):2265-77. PubMed ID: 16061945 [Abstract] [Full Text] [Related]
12. Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Ballantyne CM, Hoogeveen RC, Raya JL, Cain VA, Palmer MK, Karlson BW, GRAVITY Study Investigators. Atherosclerosis; 2014 Jan; 232(1):86-93. PubMed ID: 24401221 [Abstract] [Full Text] [Related]
13. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients. Strony J, Hoffman R, Hanson M, Veltri E. Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588 [Abstract] [Full Text] [Related]
17. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients. Averna M, Zaninelli A, Le Grazie C, Gensini GF. J Clin Lipidol; 2010 Dec; 4(4):272-8. PubMed ID: 21122660 [Abstract] [Full Text] [Related]
18. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study). Garmendia F, Brown AS, Reiber I, Adams PC. Curr Med Res Opin; 2000 Dec; 16(3):208-19. PubMed ID: 11191012 [Abstract] [Full Text] [Related]
20. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J. Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]